Emerging information surround the compound, a combined agonist for GLP-1 and GIP, illustrate significant potential in treating excess body fat and related metabolic states. Early studies show considerable weight loss https://retatrutideresearchlab.co.uk/product-category/retatrutide-peptide-finished-products/